Skip to content
Screener

Viatris VTRS Cumulative Cost Basis

Cumulative Cost Basis at other companies

ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$15.63M+173%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
AbbVie logo
AbbVieABBV
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue$3.8B+4.9%
Gross profit$1.5B+9.3%
Operating income$6.3M-97.3%
Net income-$118.8M-2,483%
EPS (diluted)-$0.10

Balance sheet

See full
Cash & equivalents$890.0M+56.7%
Total debt$13.6B-7.7%
Total equity$14.3B-8.4%
Total assets$35.0B-8.8%

Cash flow

See full
Operating cash flow$381.8M+73.8%
CapEx$52.8M-0.2%
Free cash flow$329.0M+97.2%

Valuation

See full
Market cap$18.97B+84.7%
Enterprise value$31.71B+29.6%
P/S1.3×+0.6×

Profitability

See full
Gross margin34.8%-1.8pp
Operating margin-0.6%
Net margin-2.8%-1.3pp
FCF margin13.3%+0.9pp

Returns & leverage

See full
Return on equity-2.8%-1.3pp
Debt / equity0.0×
Current ratio1.6×+0.2×

Where this comes from

Reported directly by Viatris in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.

The source filing: Viatris’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:04 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001792044-26-000041
(In millions)June 30,2026December 31, 2025
Machinery and equipment$3,056.2$3,043.4
Buildings and improvements1,537.81,527.9
Construction in progress406.9448.5
Land and improvements106.0114.9
Gross property, plant and equipment5,106.95,134.7
Accumulated depreciation2,667.22,520.7
Property, plant and equipment, net$2,439.7$2,614.0

ITEM 6. [Exhibits](#i61e5533529bd4b8b8b580f5cad6a41ec_190) [74](#i61e5533529bd4b8b8b580f5cad6a41ec_190)

FAQ

What is Viatris's cumulative cost basis?
Viatris (VTRS) reported cumulative cost basis of $5.11B in Q2 2026.
How has Viatris's cumulative cost basis changed year-over-year?
Viatris's cumulative cost basis increased by 0.8% year-over-year, from $5.07B to $5.11B.
What is the long-term trend for Viatris's cumulative cost basis?
Over 5 years (2020 to 2025), Viatris's cumulative cost basis has grown at a -2.1% compound annual growth rate (CAGR), from $5.72B to $5.13B.
What does cumulative cost basis mean?
The aggregate historical cost basis of assets or liabilities before adjustments for fair value, impairment, or amortization.

Ask your AI about Viatris's cumulative cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude